What is the role of natriuretic peptide biomarkers in population screening to detect incident HF?
Elevated plasma levels of natriuretic peptide biomarkers are associated with a wide variety of cardiac and noncardiac causes and their role in population screening to detect incident HF is emerging. Natriuretic peptide biomarkers can be used to assist in the diagnosis or exclusion of HF as a cause of symptoms such as dyspnea or weight gain, especially when the cause of dyspnea is unclear.